C. Gardham, P.E. Stevens, M.P. Delaney Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis Clin J Am Soc Nephrol 5 2010 1261 1267
S. Sardiwal, C. Gardham, A.E. Coleman Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients Kidney Int 82 2012 100 105
C.G. Fraser, E.K. Harris Generation and application of data on biological variation in clinical chemistry Crit Rev Clin Lab Sci 27 1989 409 437
G. Garrett, S. Sardiwal, E.J. Lamb PTH - a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol 2012
O.M. Gutierrez, M. Mannstadt, T. Isakova Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 2008 584 592
G. Jean, J.C. Terrat, T. Vanel High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients Nephrol Dial Transplant 24 2009 2792 2796
N. Tamei, T. Ogawa, H. Ishida Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis J Atheroscler Thromb 18 2011 217 223
M. Inaba, S. Okuno, Y. Imanishi Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients Osteoporos Int 17 2006 1506 1513
S. Vasikaran, R. Eastell, O. Bruyere Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards Osteoporos Int 22 2011 391 420
K. Shidara, M. Inaba, S. Okuno Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients Calcif Tissue Int 82 2008 278 287
